170 related articles for article (PubMed ID: 31672614)
1. Nanoemulsions and thermosensitive nanoemulgels of phenytoin and fosphenytoin for intranasal administration: Formulation development and in vitro characterization.
Pires PC; Peixoto D; Teixeira I; Rodrigues M; Alves G; Santos AO
Eur J Pharm Sci; 2020 Jan; 141():105099. PubMed ID: 31672614
[TBL] [Abstract][Full Text] [Related]
2. Intranasal fosphenytoin: The promise of phosphate esters in nose-to-brain delivery of poorly soluble drugs.
Pires PC; Santos LT; Rodrigues M; Alves G; Santos AO
Int J Pharm; 2021 Jan; 592():120040. PubMed ID: 33157214
[TBL] [Abstract][Full Text] [Related]
3. Nose-to-brain delivery of phenytoin and its hydrophilic prodrug fosphenytoin combined in a microemulsion - formulation development and in vivo pharmacokinetics.
Pires PC; Fazendeiro AC; Rodrigues M; Alves G; Santos AO
Eur J Pharm Sci; 2021 Sep; 164():105918. PubMed ID: 34174414
[TBL] [Abstract][Full Text] [Related]
4. Formulation and evaluation of itraconazole-loaded nanoemulgel for efficient topical delivery to treat fungal infections.
Patil AS; Chougale SS; Kokatanr U; Hulyalkar S; Hiremath RD; Japti V; Masareddy R
Ther Deliv; 2024 Mar; 15(3):165-179. PubMed ID: 38282577
[No Abstract] [Full Text] [Related]
5. Tocotrienols-rich naringenin nanoemulgel for the management of diabetic wound: Fabrication, characterization and comparative
Yeo E; Yew Chieng CJ; Choudhury H; Pandey M; Gorain B
Curr Res Pharmacol Drug Discov; 2021; 2():100019. PubMed ID: 34909654
[TBL] [Abstract][Full Text] [Related]
6. Transungual Delivery of Ketoconazole Nanoemulgel for the Effective Management of Onychomycosis.
Mahtab A; Anwar M; Mallick N; Naz Z; Jain GK; Ahmad FJ
AAPS PharmSciTech; 2016 Dec; 17(6):1477-1490. PubMed ID: 26857516
[TBL] [Abstract][Full Text] [Related]
7. Nanoemulgel: A Promising Phase in Drug Delivery.
Aithal GC; Narayan R; Nayak UY
Curr Pharm Des; 2020; 26(2):279-291. PubMed ID: 31878849
[TBL] [Abstract][Full Text] [Related]
8. Fosphenytoin (Cerebyx).
Browne TR
Clin Neuropharmacol; 1997 Feb; 20(1):1-12. PubMed ID: 9037568
[TBL] [Abstract][Full Text] [Related]
9. Fabrication, In Vitro, and In Vivo Assessment of Eucalyptol-Loaded Nanoemulgel as a Novel Paradigm for Wound Healing.
Rehman A; Iqbal M; Khan BA; Khan MK; Huwaimel B; Alshehri S; Alamri AH; Alzhrani RM; Bukhary DM; Safhi AY; Hosny KM
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145720
[TBL] [Abstract][Full Text] [Related]
10. Development and application of an ex vivo fosphenytoin nasal bioconversion/permeability evaluation method.
Antunes Viegas D; Rodrigues M; Francisco J; Falcão A; Alves G; Santos AO
Eur J Pharm Sci; 2016 Jun; 89():61-72. PubMed ID: 27106504
[TBL] [Abstract][Full Text] [Related]
11. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.
Fischer JH; Patel TV; Fischer PA
Clin Pharmacokinet; 2003; 42(1):33-58. PubMed ID: 12489978
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Evaluation of Novel Phenytoin-Loaded Alkyd Nanoemulsions Designed for Application in Topical Wound Healing.
Teo SY; Yew MY; Lee SY; Rathbone MJ; Gan SN; Coombes AGA
J Pharm Sci; 2017 Jan; 106(1):377-384. PubMed ID: 27522920
[TBL] [Abstract][Full Text] [Related]
13. Enhanced transdermal permeability of piroxicam through novel nanoemulgel formulation.
Dhawan B; Aggarwal G; Harikumar S
Int J Pharm Investig; 2014 Apr; 4(2):65-76. PubMed ID: 25006551
[TBL] [Abstract][Full Text] [Related]
14. Safety of fosphenytoin sodium.
Fierro LS; Savulich DH; Benezra DA
Am J Health Syst Pharm; 1996 Nov; 53(22):2707-12. PubMed ID: 8931812
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial Activity of Fusidic Acid and Sodium Fusidate Nanoparticles Incorporated in Pine Oil Nanoemulgel.
Eid AM; Istateyeh I; Salhi N; Istateyeh T
Int J Nanomedicine; 2019; 14():9411-9421. PubMed ID: 31819440
[TBL] [Abstract][Full Text] [Related]
16. The safety, tolerability, and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients.
Boucher BA; Feler CA; Dean JC; Michie DD; Tipton BK; Smith KR; Kramer RE; Young B; Parks BR; Kugler AR
Pharmacotherapy; 1996; 16(4):638-45. PubMed ID: 8840370
[TBL] [Abstract][Full Text] [Related]
17. The safety and efficacy of fosphenytoin for the treatment of status epilepticus.
Popławska M; Borowicz KK; Czuczwar SJ
Expert Rev Neurother; 2015; 15(9):983-92. PubMed ID: 26289487
[TBL] [Abstract][Full Text] [Related]
18. Design and development of letrozole nanoemulsion: A comparative evaluation of brain targeted nanoemulsion with free letrozole against status epilepticus and neurodegeneration in mice.
Iqbal R; Ahmed S; Jain GK; Vohora D
Int J Pharm; 2019 Jun; 565():20-32. PubMed ID: 31051232
[TBL] [Abstract][Full Text] [Related]
19. Development of Topical Nanoemulgel Using Combined Therapy for Treating Psoriasis.
Bhardwaj S; Gaur PK; Tiwari A
Assay Drug Dev Technol; 2022 Jan; 20(1):42-54. PubMed ID: 34883035
[TBL] [Abstract][Full Text] [Related]
20. Purple Glove Syndrome after Phenytoin or Fosphenytoin Administration: Review of Reported Cases and Recommendations for Prevention.
Garbovsky LA; Drumheller BC; Perrone J
J Med Toxicol; 2015 Dec; 11(4):445-59. PubMed ID: 26135797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
